when were glp 1 agonists discovered Timeline of GLP-1 discovery and clinical development. (a) Key events in Trends in the Development of
Description
Quiets food noise & reduces cravings*
2023 January;22(1):20-27 | doi: 10.12788/cp.0318 Evidence suggests substantial beneficial effects on weight and glycemic dysregulation
High costs serve as barrier to care High out-of-pocket costs for people without insurance coverage remain a key factor in determining who can benefit from GLP-1 medications and who cannot, said Tracy Svenyach, PhD, director of policy strategy and alliance at the Obesity Action Coalition
This is therefore another key aspect that pharmaceutical companies will need to think about when developing new drugs for the AOM market
B., Greenland J
However, adequate adjustment of insulin doses and close monitoring after GLP-1RA initiation may decrease this risk
